- Novartis plans to lay off as many as 8,000 employees worldwide as it continues a yearslong transformation into a more streamlined company, a spokesperson confirmed in an email to BioPharma Dive.
- The Swiss drugmaker is implementing new organizational setups at its headquarters and elsewhere and is working to “rationalize” functions such as finance, legal, communications and engagement. The result will be a “leaner and simpler” structure for Novartis as a whole, the spokesperson said.
- The cuts amount to more than 7% of the company’s global workforce of 108,000. In Switzerland, Novartis plans to eliminate about 1,400 positions, or 12% of the 11,600 jobs in its home country, the spokesperson added. Swiss newspaper Tages-Anzeiger first reported the layoffs on Tuesday.